Chemotherapy: Adjuvant TKIs in NSCLC: What can we learn from RADIANT?

Fred R. Hirsch, Paul A. Bunn

Research output: Contribution to journal › Short survey › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	689-690
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	12
Issue number	12
DOIs	https://doi.org/10.1038/nrclinonc.2015.202
State	Published - 1 Dec 2015
Externally published	Yes

Access to Document

@article{db909f6966e849b4baf2b437033d71a8,

title = "Chemotherapy: Adjuvant TKIs in NSCLC: What can we learn from RADIANT?",

author = "Hirsch, {Fred R.} and Bunn, {Paul A.}",

year = "2015",

month = dec,

day = "1",

doi = "10.1038/nrclinonc.2015.202",

language = "English",

volume = "12",

pages = "689--690",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Chemotherapy

T2 - Adjuvant TKIs in NSCLC: What can we learn from RADIANT?

AU - Hirsch, Fred R.

AU - Bunn, Paul A.

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84948379595&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2015.202

DO - 10.1038/nrclinonc.2015.202

M3 - Short survey

C2 - 26552954

AN - SCOPUS:84948379595

SN - 1759-4774

VL - 12

SP - 689

EP - 690

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 12

ER -